Treatment of spider telangiectases in children using the flashlamp-pumped pulsed dye laser

R G Geronemus1

  • 1Department of Dermatology, New York University School of Medicine, New York 10016.

Pediatric Dermatology
|March 1, 1991
PubMed

Insights

A pulsed dye laser effectively treated spider telangiectases in children. The 585 nm wavelength laser achieved complete resolution of facial vascular lesions without scarring.

Area of Science:

  • Dermatology
  • Medical Technology
  • Pediatric Medicine

Background:

  • Spider telangiectases are common facial vascular malformations.
  • Treatment options for pediatric facial vascular lesions can be limited.

Purpose of the Study:

  • To evaluate the efficacy of a pulsed dye laser in treating spider telangiectases in children.
  • To assess the safety and cosmetic outcomes of laser treatment for pediatric facial vascular lesions.

Main Methods:

  • Twelve children aged 2-10 years with facial spider telangiectases were enrolled.
  • Treatment involved a flashlamp-pumped pulsed dye laser (585 nm wavelength, 450 microsec pulse width).

Main Results:

  • Complete resolution of spider telangiectases was observed in all 12 pediatric patients.
  • No scarring or permanent pigmentary alterations were reported post-treatment.

Conclusions:

  • Pulsed dye laser therapy is a safe and effective treatment for facial spider telangiectases in children.
  • This laser modality offers excellent cosmetic results without adverse skin effects.